Olmesartan Medoxomil (CS-866)

olmesartan medoxomil · Daiichi Sankyo Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Olmesartan Medoxomil (CS-866), covering 2010-09-29 to 2010-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy [Phase 2]

See pricing